What Biogen CEO saidThis is what Biogen's CEO said: "We are working toward the goal of creating an environment where detection of the disease is as early, widespread and routine as mammograms and colonoscopies." This should increase Alzheimer's testing & CGN's ICA testing exponentially going forward. The general population over age 30-35 will need to be tested annually. Good to see some investors connecting the dots today.